MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-02-2026
Surgery Partners Cost of Revenue 2011-2026 | SGRY
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Surgery Partners
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 971 M | 908 M | 794 M | 746 M | 644 M | 550 M | 1.41 B | 1.36 B | - | 821 M | 669 M | 254 M | 170 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.41 B | 170 M | 775 M |
Quarterly Cost of Revenue Surgery Partners
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 243 M | 235 M | - | 228 M | 223 M | 215 M | - | 195 M | 195 M | 202 M | - | 186 M | 182 M | 179 M | - | 162 M | 155 M | 152 M | - | 142 M | 116 M | 140 M | 388 M | 353 M | 340 M | 326 M | 360 M | 334 M | 340 M | 327 M | 339 M | 103 M | 216 M | 212 M | 214 M | 201 M | 209 M | 197 M | 183 M | 169 M | 162 M | 156 M | 121 M | 45.4 M | 45.2 M | 43 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 388 M | 43 M | 208 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Chemed Corporation
CHE
|
1.58 B | $ 422.97 | 0.4 % | $ 6.35 B |  USA |
 |
Addus HomeCare Corporation
ADUS
|
961 M | $ 103.45 | -1.72 % | $ 1.87 B | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.46 | -1.85 % | $ 453 M |  China |
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B | USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
The Ensign Group
ENSG
|
4.02 B | $ 212.84 | -1.39 % | $ 12.2 B | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.43 M | - | 26.45 % | $ 70.6 M | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 23.33 | -0.6 % | $ 7.05 B |  Germany |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.62 | 0.7 % | $ 125 M | USA |
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M | China |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
Encompass Health Corporation
EHC
|
3.12 B | $ 108.17 | 0.08 % | $ 10.9 B | USA |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 22.87 | -2.43 % | $ 2.1 B | USA |
 |
HCA Healthcare
HCA
|
32.9 B | $ 540.53 | 1.44 % | $ 128 B | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
896 M | $ 52.54 | -3.67 % | $ 2.13 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 21.06 | 3.11 % | $ 825 M | USA |
 |
American Shared Hospital Services
AMS
|
19.2 M | $ 2.08 | -0.95 % | $ 13.5 M | USA |
 |
Healthcare Services Group
HCSG
|
1.6 B | $ 21.36 | -3.87 % | $ 1.55 B | USA |
 |
Select Medical Holdings Corporation
SEM
|
4.82 B | $ 16.25 | 8.33 % | $ 1.99 B | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
Community Health Systems
CYH
|
1.86 B | $ 3.45 | 1.92 % | $ 461 M | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
2.12 B | $ 24.9 | -4.49 % | $ 12.4 B | USA |
|
Sanara MedTech
SMTI
|
7.85 M | $ 20.83 | 1.71 % | $ 172 M | USA |
 |
The Pennant Group
PNTG
|
769 M | $ 32.76 | -3.13 % | $ 1.13 B | USA |
 |
MEDNAX
MD
|
1.54 B | $ 19.66 | 0.46 % | $ 1.65 B | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
National HealthCare Corporation
NHC
|
921 M | $ 170.6 | -0.32 % | $ 2.64 B | USA |
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | USA |
 |
Option Care Health
OPCH
|
4.56 B | $ 31.18 | -1.33 % | $ 5.05 B | USA |
 |
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | USA |
 |
Tenet Healthcare Corporation
THC
|
8.7 B | $ 242.28 | 3.21 % | $ 21.8 B | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
U.S. Physical Therapy
USPH
|
462 M | $ 82.7 | -0.23 % | $ 1.25 B | USA |
 |
Universal Health Services
UHS
|
8.08 B | $ 204.6 | -0.78 % | $ 13 B | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |